Communiqués

17/08 Acarix (Q2 Review): Laying the groundwork AQ
13/08 Acarix (Q2 Initial take): In line with estimates AQ
13/08 Acarix Publishes Second Quarter and First Half 2026 Results AQ
11/08 Acarix Receives Regulatory Approval for the CADScor(R) System in the UAE (United Arab Emirates) AQ
10/08 Acarix Receives Regulatory Approval for the CADScor®System in the United Arab Emirates AQ
17/06 Announcement from the annual general meeting in Acarix AB AQ
16/06 Proposals of the Nomination Committee for the Annual General Meeting of Acarix AB (publ) on June 17, 2026 AQ
19/05 Acarix (Q1 Review): Continued US traction and improved cost base AQ
19/05 Acarix : Notice AGM 2029 (ENG) (Notice Acarix AB final 2026 05 1818540034) PU
18/05 NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB AQ
18/05 Acarix : Q1 2026 (Acarix Q12026 English Report 2605150747 FINAL) PU
18/05 Acarix Publishes Interim Report, January – March 2026 AQ
04/05 Acarix Changes Publication Date for Q1 2026 Interim Report AQ
15/04 Acarix AB’s Annual Report 2025 AQ
15/04 Acarix : 2025 ANNUAL REPORT-ENGLISH (Acarix English Annual 2025 Report Final) PU
08/04 ACARIX PRESENTS ABSTRACT AT ACC.26 HIGHLIGHTING CADSCOR® SYSTEM'S DIAGNOSTIC UTILITY COMPARED TO STANDARD STRESS TESTS IN CHEST PAIN PATIENTS AQ
13/02 Acarix (Q4 review): A solid end to 2025 AQ
12/02 Acarix Publishes Year-End Report 2025 AQ
12/02 Acarix : Q4 2025 (Acarix Q4 Interim Report Final) PU
11/02 Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System AQ
04/02 Acarix Receives EU MDR Certification for the CADScor®System AQ
08/12 ACARIX CARRIES OUT A DIRECTED SHARE ISSUE OF APPROX. SEK 33.4 MILLION AQ
06/11 Invitation to presentation of Acarix´s third quarter 2025 report AQ
06/11 Acarix : Q3 2025 ENGLISH (Acarix Q3 English Report Final 2511050933) PU
06/11 Acarix Publishes Interim Report, Third quarter 2025 AQ
Aucun résultat pour cette recherche